Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation

2018-06-20T14:08:12+00:00

Fortress Biotech, formerly Coronado Biosciences Inc, announces publication in the journal Biology of Blood and Marrow Transplantation of positive Phase 1 clinic [...]

Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation2018-06-20T14:08:12+00:00

Freeline secures over £88 million of funding

2018-06-22T11:29:26+00:00

London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with liver targeted ad [...]

Freeline secures over £88 million of funding2018-06-22T11:29:26+00:00